Stay updated on XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page.

Latest updates to the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.7%
- Check14 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as multiple updates to study statuses and recruitment information. However, several location-related terms have been removed.SummaryDifference26%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check35 days agoChange DetectedThe web page has updated its version from v2.16.10 to v2.16.11 and changed the date from 2025-05-09 to 2025-08-06.SummaryDifference1.0%
- Check42 days agoChange DetectedThe page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference4%
- Check50 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.SummaryDifference0.8%
Stay in the know with updates to XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb24306+Cevostamab Safety/PK/Activity in Multiple Myeloma Clinical Trial page.